The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...

ASCO’s patient education resources are reviewed by ASCO’s Patient Information Editorial Board, composed of 200+ medical, surgical, radiation, and pediatric oncologists; multidisciplinary members of ...

Learn about the 2025 Conquer Cancer Grants & Awards recipients.

The Quality Oncology Practice Initiative Certification Program provides a three-year certification recognizing high-quality care for outpatient hematology-oncology practices within the United States.

The exhibitor and advertiser policies establish the general standards ASCO and its affiliates apply to the activities of commercial firms and other organizations, including not-for-profit ...

The FASCO designation honors members for their extraordinary volunteer service, engagement, and dedication to the American Society of Clinical Oncology and the Association for Clinical Oncology ...

Information about the ASCO Annual Meeting for media, including registration instructions and press releases.

Thank you for your interest in the ASCO Plenary Series. Effective June 2024, the Series will pause indefinitely and is not accepting abstract submissions. With greatly increased demand for in-person ...

This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...

The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer re ...

ASCO provides numerous quality activities aimed at improving the standard of cancer care received by patients in the United States and around the world. ASCO Certified ASCO Certified is a program that ...

The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology.